Back to Search Start Over

Testing behaviour and positivity for SARS-CoV-2 infection: insights from web-based participatory surveillance in the Netherlands.

Authors :
McDonald SA
Soetens LC
Schipper CMA
Friesema I
van den Wijngaard CC
Teirlinck A
Neppelenbroek N
van den Hof S
Wallinga J
van Hoek AJ
Source :
BMJ open [BMJ Open] 2021 Dec 21; Vol. 11 (12), pp. e056077. Date of Electronic Publication: 2021 Dec 21.
Publication Year :
2021

Abstract

Objectives: We aimed to identify populations at a high risk for SARS-CoV-2 infection but who are less likely to present for testing, by determining which sociodemographic and household factors are associated with a lower propensity to be tested and, if tested, with a higher risk of a positive test result.<br />Design and Setting: Internet-based participatory surveillance data from the general population of the Netherlands.<br />Participants: Weekly survey data collected over a 5-month period (17 November 2020 to 18 April 2021) from a total of 12 026 participants who had contributed at least 2 weekly surveys was analysed.<br />Methods: Multivariable analyses using generalised estimating equations for binomial outcomes were conducted to estimate the adjusted ORs of testing and of test positivity associated with participant and household characteristics.<br />Results: Male sex (adjusted OR for testing (OR <subscript>t</subscript> ): 0.92; adjusted OR for positivity (OR <subscript>p</subscript> ): 1.30, age groups<20 (OR <subscript>t</subscript> : 0.89; OR <subscript>p</subscript> : 1.27), 50-64 years (OR <subscript>t</subscript> : 0.94; OR <subscript>p</subscript> : 1.06) and 65+ years (OR <subscript>t</subscript> : 0.78; OR <subscript>p</subscript> : 1.24), diabetics (OR <subscript>t</subscript> : 0.97; OR <subscript>p</subscript> : 1.06) and sales/administrative employees (OR <subscript>t</subscript> : 0.93; OR <subscript>p</subscript> : 1.90) were distinguished as lower test propensity/higher test positivity factors.<br />Conclusions: The factors identified using this approach can help identify potential target groups for improving communication and encouraging testing among those with symptoms, and thus increase the effectiveness of testing, which is essential for the response to the COVID-19 pandemic and for public health strategies in the longer term.<br />Competing Interests: Competing interests: None declared.<br /> (© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.)

Details

Language :
English
ISSN :
2044-6055
Volume :
11
Issue :
12
Database :
MEDLINE
Journal :
BMJ open
Publication Type :
Academic Journal
Accession number :
34933864
Full Text :
https://doi.org/10.1136/bmjopen-2021-056077